Clinical Trials Logo

Tumor Vaccines clinical trials

View clinical trials related to Tumor Vaccines.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT01863108 Completed - Melanoma Clinical Trials

Safety Study of a Dendritic Cell-based Cancer Vaccine in Melanoma

GeniusVac-Mel4
Start date: June 2013
Phase: Phase 1
Study type: Interventional

The primary objective of this study is to evaluate the safety and tolerability of multiple sub-cutaneous injections of GeniusVac-Mel4, a dendritic cell-based cancer vaccine, in patients with melanoma. The secondary objectives are to determine immune response and clinical efficacy of such injections in patients with melanoma.